Stay updated on Rituximab in Eosinophilic Granulomatosis Clinical Trial

Sign up to get notified when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rituximab in Eosinophilic Granulomatosis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The record now presents details of the completed REOVAS trial comparing rituximab-based treatment with conventional therapy for eosinophilic granulomatosis with polyangiitis. It includes participant criteria, study arms and outcomes, investigator and location information, and a related publication.
    Difference
    61%
    Check dated 2026-11-07T12:18:15.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site revision shown in the footer changed from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T12:53:41.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov error page.
    Difference
    1%
    Check dated 2026-10-24T12:27:03.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:30:30.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:23:14.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    A 403 Forbidden error page now appears, replacing the study record content and signaling blocked access to the page.
    Difference
    20%
    Check dated 2026-09-19T18:34:21.000Z thumbnail image

Stay in the know with updates to Rituximab in Eosinophilic Granulomatosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.